CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Telehealth monitoringWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (5)

Name (Synonyms) Correlation
drug948 Recombinant Human Interferon α2b Spray Wiki 1.00
drug80 Arbidol Hydrochloride Granules Wiki 1.00
drug188 Bromhexine Hydrochloride Tablets Wiki 1.00
drug749 Niclosamide Wiki 0.71
drug850 Placebo Wiki 0.09

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.07
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Niclosamide for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19)

This study will evaluate the antihelmintic drug, Niclosamide, as a potential treatment for mild to moderate coronavirus disease 2019 (COVID-19).

NCT04399356 COVID (SARS-CoV-2) Drug: Niclosamide Drug: Placebo Other: Telehealth monitoring

Primary Outcomes

Description: Oropharangeal swab

Measure: Change in respiratory viral clearance (by PCR)

Time: Day 3 and 10

Secondary Outcomes

Description: Fecal swab

Measure: Fecal viral clearance (by PCR)

Time: Day 14

Description: Oropharngeal swab

Measure: Reduction (change) in viral shedding (by PCR)

Time: Days 1,3,7,10,14

No related HPO nodes (Using clinical trials)